Inactive Instrument

Analyst Reco. Capricor Therapeutics Inc Nasdaq

Equities

HC Wainwright Raises Price Target on Capricor Therapeutics to $40 From $18, Keeps Buy Rating	23-10-04	MT
Ladenburg Thalmann Starts Capricor Therapeutics at Buy With $15 Price Target	22-10-26	MT
HC Wainwright Adjusts Capricor Therapeutics' Price Target to $18 From $14, Reiterates Buy Rating	22-01-31	MT
CAPRICOR THERAPEUTICS : HC Wainwright Boosts Price Target on Capricor Therapeutics to $14 From $9, Keeps Buy Rating	21-10-11	MT

No results for this search